Source: Annual Congress 2002 - Cystic fibrosis: problem infections and new monitoring techniques
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Jung, F. Ratjen, M. Griese, E. Rietschel, M. Ballmann, G. Döring, K. P. Paul (Berlin, Munich, Germany). Diagnostic values of airway samples and serum antibodies for P. aeruginosa in cystic fibrosis. Eur Respir J 2002; 20: Suppl. 38, 1367

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic value of serological tests against Pseudomonas aeruginosa in cystic fibrosis patients Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Detection of antibodies against Pseudomonas aeruginosa in the sputum of cystic fibrosis patients: A pilot study Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research Year: 2012 Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis Source: Eur Respir J 2011; 37: 553-558 Year: 2011 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Does sputum induction improve Pseudomonas aeruginosa detection in cystic fibrosis? Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003 Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007 Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis Source: Eur Respir J 2004; 24 : 631-637 Year: 2004 Pneumococcal antibody levels in children with cystic fibrosis (CF) Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis Source: Eur Respir J 2009; 33: 305-311 Year: 2009 Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa Source: Eur Respir J, 50 (1) 1601569; 10.1183/13993003.01569-2016 Year: 2017 Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis Source: Eur Respir J 2009; 34: 1079-1085 Year: 2009 Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 The diagnostic value of pseudomonas aeruginosa serology as markers of early respiratory infection in young children with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage Year: 2007 Serial measures of airway function in infants & preschoolers with cystic fibrosis (CF) according to pseudomonas aeruginosa (PsA) status Source: Eur Respir J 2007; 30: Suppl. 51, 449s Year: 2007 The identification of bacterial strains in specimens of adult cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004 Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003 Host specificity of pseudomonas aeruginosa isolates from patients with cystic fibrosis and patients from different clinical backgrounds Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Robustness of assessment of pulmonary endpoints in phase 3 trials with ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients with chronic Pseudomonas aeruginosa (PA) infections Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018